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 Pedunculated hepatoma (hepatocellular carcinoma ; HCC) 
showing an extrahepatic growth is very rare. In order to 
clarify the clinical and pathological features and problems 
presented by this tumor, seven patients in our hospitals were 
reviewed. All patients were men and the average age was 64 
years. Tumors originated from the lateral segment in 3 
patients, anterior segment in 2, and medial segment and 
quadrate lobe in one patient each, and ranged in size from 7 
cm to 21 cm with pedicles (2-7 cm) corresponding to the liver 
tissue. Underlying liver disease was found in 6 patients ; 
cirrhosis and chronic hepatitis in 3 patients each. Initial 
symptoms were abdominal pain and palpable abdominal 
mass. Imaging modalities including US, CT and angio-
graphy could not adequately demonstrate definite findings of 
this tumor arising from the liver. Serum AFP was normal or 
slightly elevated in 3 patients. Pathologically, pedunculated 
tumors showed expansive growth with septum formation and 
complete capsule, with a portal vein thrombus and/or 
frequent satellite tumors. The postoperative outcomes of the 
5 patients were excellent in only one patient. The other 4 
patients died of hepatic recurrence of the tumor within 3 
years. This study suggests that early detection of small 
pedunculated HCC and an adequate resection margin are the 
most important factors for the prognosis of patient.
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Introduction 
 Although hepatocellular carcinoma (HCC) is not a rare 
disease in Japan, extrahepatic growth of HCC is ex-
tremely uncommon. Edmondson and Steiner, in their 
histopathologic study of primary liver cancers, described 
macroscopically an extrahepatic growth of HCC as 
pedunculated hepatoma1 . The morphological and etiolo-
gical events of the lesion have been frequently discribed,
but no clinical features relevant to the etiology of 
pedunculated HCC have been identified"). This paper 
reviews our experience of 7 patients with pedunculated 
HCC with particular reference to clinical features and 
pathological factors affecting patient survival').
Patients and Materials 
 Of 165 hepatocellular carcinoma patients treated in our 
hospitals since 1972, seven patients (4.2%) with peduncu-
lated hepatoma were retrospectively reviewed. All patients 
were histologically confirmed as HCC in 6 resected speci-
mens and one autopsy. Clinical and pathological findings 
were evaluated on the basis of the General Rules for the 
Clinical and Pathological Study of Primary Liver Cancer').
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Results 
Clinical Features 
 All patients were men ranging from 53 to 83 years in 
age, with an average of 64 years (Table 1). Primary sites 
of the tumor were the lateral segment in 3 patients, 
anterior segment in 2, and medial segment and quadrate 
lobe in one, each. Initial symptom and physical findings 
were usually nonspecific. All patients had a palpable mass 
on the upper abdomen. Five patients presented with 
abdominal pain and fever. Two patients (cases 4 and 6) 
were admitted with sudden onset of abdominal pain due to 
spontaneous rupture of HCC. One patient (case 7) had 
rupture of a metastatic nodule in the liver. The other 
patient (case 6) presented with a subcapsular rupture of a 
pedunculated tumor originating from the median segment 
of the liver. 
 Ultrasonography (US) and computed tomography (CT) 
were performed in 5 and angiography in 6 patients (Table 
2), but definite findings of the tumor arising from the 
liver could not be adequately demonstrated in these images 
(Fig. 1). In one patient presenting with a mobilable tumor
Table 1. Clinical Features of Pedunculated Hepatoma 
      No. 1 2 3 4 5 6 7 
     Age •Sex 63•M 53•M 83•M 57•M 62•M 56•M 71•M 
 Tumor 
 Location A(S5) A(SS) L(S3) Q(So M(S4) L(S3) L(S3) 
 Size(cm) 14 x 16 21 x 11 7 x 6 10 x 10 7.8 x 6 7.5 x 7 21 x 18 
 Pedicle (cm) 7.0 5.0 3.0 7.0 3.2 3.5 2.0
 Treatment HRo HR2(L,M) HRo TAE HRo HRo HR2(L,M) 
 Prognosis 3Y1M died 3Y1M died 3Y1M died 3Y1M died 3Y1M died 3Y1M died 3Y1M died
Table 2. Clinical Examination on Admission 
      No. 1 2 3 4 5 6 7 
     Age •Sex 63•M 53•M 83•M 57•M 62•M 56•M 71•M 
 Angiogram + + NE + + + + 
 CT-scan NE NE + +(multiple) + + + 
 Ultrasonography NE NE + + + + + 
 AFP (ng/ml) 18 - - 4.3 23 48.8 559.6 
 HBs-Ag NE - - + - - -
 HBs-Ab NE - - - - - -
NE: not examined, (+) : positive findings.
(case 3) CT scan showed a large tumor occupying the right 
upper abdominal cavity (Fig. 2). Operation revealed a 
pedunculated HCC arising from the left hepatic lobe and 
shifting to the left hypochondrium (Fig. 3). 
 The serum AFP and HBsAg values of patients are 
tabulated in Table 2. In 6 out of 7 patients, the serum AFP 
value was normal or slightly below 100 ng/ml. Only one 
patient (case 7) had abnormal levels of 559.6 ng/ml. One 
patient was positive for serum HBsAg.
Fig. 2. CT-scan of case 3 showing a large tumor in the reight 
upper abdominal cavity.
Fig. 1. Hepatic arteriography of case 2. The parenchymal 
blush of the branch of hepatic artery and middle colic artery 
are seen.
Fig. 3. Resected specimen of case 3 showing 7 x 6 cm encap-
sulated massive tumor with 3 cm pedicle.
Table 3. Pathological Findings of Tumor 
      No. 1 2 3 4 5 6 7 
     Age •Sex 63•M 53•M 83•M 57•M 62•M 56•M 71•M
 fc + + + + + + + 
 fc-inf + + + + + + + + + + 
 vp - + + + + - -
 Edmondson's II III III I II II II III • N II• III 
 grade 
 Underlying PC LC none PC CH PC LC 
 liver disease 
fc: : fromation of capsule, fc-inf : capsular invasiojn of cancer cells. 
(-) : no invasion, (+) : intracapsular invasion, (+ +) : cancer invasion extending through capsule. 
CH : chronic hepatitis, PC : precirrhosis, LC : liver cirrhosis.
cm to 21 cm with a tumor pedicle (2-7 cm) corresponding 
to the liver. Grossly, the tumors were firmly encapsulated 
by fibrous connective tissues, and were separated from the 
liver by this capsule in the pedicle of the tumor. The cut 
surface of the tumors also showed several septum toward 
the periphery from the core (Fig. 4). The invasion of HCC 
extending through the capsule was noted in all cases. 
Microscopically, the presence of tumor thrombus in the 
portal vein (vpi) was detected in 4 cases (57%).
Fig. 4. Cut surface of the tumor (case 2) showing several 
septum toward the periphery from the centrum.
Operation and Prognosis 
 One patient with spontaneous rupture of HCC (case 7) 
was managed by lipiodolization with 20 mg of mitomycin 
C. The patient died of hepatic failure associated with DIC 
7 days after TAE. Autopsy revealed a huge pedunculated 
HCC arising from left lobe and a rupture of metastatic 
tumor in anterior segment. Tumors in 6 out of 7 patients 
were surgically removed. Five patients underwent partial 
hepatic resection around the pedicle of the tumor (Fig. 5). 
The operations were considered to be radical in all patients 
judged by intraoperative findings and US and/or CT. The 
patient who underwent right lobectomy (Case 2) subse-
quently developed hepatic failure and died 6 days after 
surgery. The postoperative outcomes of the 5 patients were 
excellent in only one patient. The other 4 patients died of 
hepatic recurrence of the tumor within 3 years.
Fig. 5. Operative finding of case 1 showing a large tumor 
originating from right lobe of the liver.
Pathologic Features 
 Pathologic findings of the tumors removed at operation 
or autopsy are summarized in Table 3. Six out of 7 patients 
(86%) had underlying liver disease ; chronic hepatitis in 
one (14%), precirrhosis in 3 (43%) and cirrhosis in 2 
(29%). There was one patient with no underlying liver 
disease. The maximum diameter of tumors ranged from 7
Discussion 
 Goldberg and Wallenstein first reported in 1934 an 
extrahepatic growth of HCC arising from the lower 
surface of the left lobe, with a pedicle of about 1.5 cm in 
diameter", and Edmondson and Steiner described this type 
of HCC as pedunculated hepatoma in 1954'). Since these 
descriptions, several reports have discussed the clinical and 
pathological features of pedunculated HCC. However, no 
relevant morphological or etiological events of tumor 
progression were identified. Goldberg et al. suggested that 
such an extrahepatically growing HCC might arise from 
congenitally displaced lobules in Glisson' capsule" .
Miyoshi et al. also suggested that a pedunculated HCC 
could arise from an accessory lobes). Accessory lobes are 
often found on the right main lobe, and are frequently 
attached by pedicles containing blood vessels and bile 
ducts. They are also often found on the inferior surface of 
the right lobe, and anatomically, they are found every-
where on the hepatic lobes"). On the other hand, in pa-
tients with HCC associated with cirrhosis, it is possible 
that the protruding site of liver cirrhosis may become an 
extrahepatically growing HCC3) A pedunculated HCC may 
also arise from ectopic liver tissue. Ectopic liver tissue has 
been found at various sites, including the triangular 
ligament of the liver, spleen, umbilical fossa, omentum, 
retroperitoneium near the celiac axis, and in the gallblad-
der and its vicinitya9). 
  The present series in the pedunculated tumor which 
exhibited a mobile pedicle and no underlying liver tissues 
(case 4) appeared to arise from an accessory lobe. In the 
other 6 patients, pathologic findings of the tumors seem to 
be characteristic. The tumors had a long pedicle and 
showed expansive growth with formation of a septum 
toward the periphery from the tumor centrum and com-
plete capsule formation. This may be morphological 
evidence that these tumors may also arise from an acces-
sory lobe rather than developing from the surface of 
cirrhotic liver. Tumor-associated symptoms in patients 
with HCC are uncommon, even in advanced stages. In our 
series, unusual presentations, such as a palpable mass, 
intractable pain, fever and periodic follow-up examination 
for underlying liver disease led to tumor detection. Two 
patients represented spontaneous rupture of HCC. Several 
factors contributing to rupture of HCC have been pointed 
out') : pathologically, 1) encapsulated tumor, 2) capsule 
invasion of cancer cells, 3) portal tumor thrombus, 4 ) 
tumor size, and physiologically, 1) neovascularization, 2 ) 
increased intrahepatic shunting, 3) obstruction of bra-
nches of the hepatic vein draining the tumor bearing area, 
4) portal hypertension due to preexisting cirrhosis. In the 
current series, we recognized the presence of these patho-
logical features in all ceses. The incidence of spontaneous 
rupture of HCC in Asia or Africa were 4-14.5%10.11), but 
spontaneous rupture of pedunculated HCC was uncomm-
ona13). The physiological factors seems to play important 
roles in the pathogenesis of the spontaneous rupture. 
Abdominal pain was also found in one patient presenting 
with a mobilable tumor. In patient with pedunculated 
HCC, abdominal symptoms might be caused by mobiliza-
tion or torsion of tumor in the same genesis for sympto-
matic accessory lobe of the liver,"). 
 Serum AFP has been frequently used to screen for HCC 
to differentiate it from other abdominal tumors. In the 
Japan series, the positive rate of AFP for pedunculated 
HCC was 66% showing almost equal incidence of all HCC 
with 68% in 19971,14). However, serum AFP measurement 
was not the first diagnostic clue for pedunculated HCC in
any of our patients, and most of the patients (6 out of 7) 
showed normal or slightly elevated levels that remained 
below 100 ng/ml. Thus , initial and laboratory abnormali-
ties are generally minimal with this tumor, so that the 
role of imaging procedures for diagnosis of the tumor is 
important. 
 According to our Japanese series, hepatic angiography, 
computed tomography, and ultrasonography, which were 
performed in approximately 90% of the HCC patients, 
demonstrated positive findings in 90% patients tested"). 
Angiography may provide useful information on the 
vascular supply the tumors with hypervascular encapsula-
tion. However, it was difficult to differentiate peduncu-
lated HCC from tumors of other organs which often 
infiltrated the liver with neovascularization from hepatic 
vessels","). 
 For operation of pedunculated HCC, the resectability 
rate was relatively high at 65% in this Japanese series". 
Most tumors were removed by minute procedures such as 
wedge resection or subsegmentectomy. However, the 
prognosis was still poor despite curative resection. This 
was attributed to the advanced stage of the lesions due to 
delayed diagnosis. In previous reports, we have identified 
several important pathologic features of HCC affecting 
the prognosis'). These include the size of the tumor, the 
presence of tumor thrombus in portal vein, capsule inva-
sion, intrahepatic metastasis, underlying liver diseases, 
and an adequate resection margin. In the current series, we 
confirmed this fact with a review of the literature. 
 In conclusion, early detection of small pedunculated HCC 
and an adequate hepatic resection for cirrhotic liver are 
most important for good prognosis of the patients.
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